• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594166)   Today's Articles (3964)   Subscriber (49325)
For: Campbell L, Panitsas F, Basu S, Anyanwu F, Lee S, Ferry B, Ramasamy K. Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma. Br J Haematol 2018;185:775-778. [PMID: 30338523 DOI: 10.1111/bjh.15615] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Number Cited by Other Article(s)
1
Rath A, Panda T, Dass J, Seth T, Mahapatra M, Tyagi S. Minimal residual disease analysis in multiple myeloma: A single-center experience. JOURNAL OF APPLIED HEMATOLOGY 2023. [DOI: 10.4103/joah.joah_69_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]  Open
2
Dold SM, Riebl V, Wider D, Follo M, Pantic M, Ihorst G, Duyster J, Zeiser R, Wäsch R, Engelhardt M. Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma. Haematologica 2020;105:e523. [PMID: 33054097 PMCID: PMC7556664 DOI: 10.3324/haematol.2019.238394] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA